Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”

We recently read with interest the original research article entitled "Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy". The abovementioned article is an observational retrospective cohort study, which could be...

Descripción completa

Detalles Bibliográficos
Autores principales: Argyriou, Konstantinos, Kotsakis, Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403700/
https://www.ncbi.nlm.nih.gov/pubmed/36159549
http://dx.doi.org/10.12998/wjcc.v10.i23.8425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403700/
https://www.ncbi.nlm.nih.gov/pubmed/36159549
http://dx.doi.org/10.12998/wjcc.v10.i23.8425

Ejemplares similares